Biotech | April 06, 2022
BioFluidica to introduce next-generation biomarker isolation platform
BioFluidica LiquidScan harnesses the power of microfluidics
BioFluidica LiquidScan harnesses the power of microfluidics
Ind-Ra maintains a neutral outlook for healthcare in FY23
The kidney swap transplant procedure provides a solution to a critical shortage of compatible kidneys for patients suffering from kidney failures in India
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Lupin is committed to providing new affordable treatment options to healthcare providers and patients
If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
There is also a strong synergy between Jubilant and Greencure with respect to OTC portfolio which can be explored for R&D, online acceleration and offline distribution
Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India
The mAbxience partnership will enable Cipla to continue its ethos of ensuring equitable access to affordable, life-saving medication
Subscribe To Our Newsletter & Stay Updated
